Provided by Tiger Trade Technology Pte. Ltd.

FibroBiologics

1.07
-0.0700-6.14%
Volume:20.02K
Turnover:22.36K
Market Cap:7.12M
PE:-0.22
High:1.13
Open:1.12
Low:1.06
Close:1.14
52wk High:10.33
52wk Low:0.6201
Shares:6.66M
Float Shares:5.42M
Volume Ratio:1.21
T/O Rate:0.37%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.7656
EPS(LYR):-8.3501
ROE:-660.08%
ROA:-95.77%
PB:1.54
PE(LYR):-0.13

Loading ...

Fibrobiologics Announces Australian Patent Accepted for Cannabidiol Adjuvant Therapy for the Treatment of Degenerative Disc Disease

THOMSON REUTERS
·
Aug 20

FibroBiologics announces laboratory findings in joint cartilage repair

TIPRANKS
·
Aug 18

FibroBiologics Says Chondrocyte Spheroids Repair Cartilage in Preclinical Degenerative Joint Study

Reuters
·
Aug 18

U.S. Stocks on the MOVEX-Abbott, Columbia Financial, Jabil,

Reuters
·
Aug 11

Fibrobiologics Granted US Patent Covering the Use of Fibroblasts

Reuters
·
Aug 11

FibroBiologics Gains on Patent Related to Insulin-Producing Cell Transplant Technology

Reuters
·
Aug 11

FibroBiologics Wins US Patent on Fibroblast-Assisted Islet Transplant Engraftment for Type 1 Diabetes

Reuters
·
Aug 11

Fibrobiologics Granted U.S. Patent Covering the Use of Fibroblasts to Enhance Survival and Function of Transplanted Insulin-Producing Islets

THOMSON REUTERS
·
Aug 11

FibroBiologics Wins European Patent for Sox9 Gene Therapy to Regenerate Cartilage

Reuters
·
Aug 05

Fibrobiologics Granted European Patent Covering Gene Therapy for the Regeneration of Cartilage

THOMSON REUTERS
·
Aug 05

FibroBiologics Q2 2026 Earnings: CYWC628 Dosing Begins With $3.5 Million in Cash

TradingKey
·
Aug 05

FibroBiologics is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Aug 04

U.S. Research Roundup-Cloudflare, Replimune, Walmart

Reuters
·
Aug 04

FibroBiologics Faces Material Clinical Trial and Regulatory Risks That Threaten Commercialization Timeline and Long-Term Outlook

TIPRANKS
·
Aug 02

Fibrobiologics Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 01

FibroBiologics, Inc. - Common Stock Q2 EPS $(0.66) Beats $(0.72) Estimate

Benzinga Earnings
·
Aug 01

Press Release: FibroBiologics Reports Second Quarter 2026 Financial Results; Progresses Clinical Trial Evaluating Lead Wound Care Candidate

Dow Jones
·
Aug 01

Fibrobiologics Reports Second Quarter 2026 Financial Results; Progresses Clinical Trial Evaluating Lead Wound Care Candidate

THOMSON REUTERS
·
Aug 01

Fibrobiologics - Interim Results for Cywc628 Trial Expected in Second Half of 2026

THOMSON REUTERS
·
Aug 01

Fibrobiologics Q2 FY26 Net Loss Narrows to $4.12 Million from Year-ago Quarter

Reuters
·
Aug 01